Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum.
Identifying the most effective companies isn’t easy, and that’s why we started StockStory. That said, here are three cash-producing companies that reinvest wisely to drive long-term success.
Shift4 (FOUR)
Trailing 12-Month Free Cash Flow Margin: 9.6%
Starting as a payment gateway provider in 1999 and now processing over $200 billion in annual payment volume, Shift4 Payments (NYSE: FOUR) provides integrated payment processing solutions and software that help businesses accept and manage transactions across in-store, online, and mobile channels.
Why Are We Backing FOUR?
- Impressive 27.7% annual revenue growth over the last two years indicates it’s winning market share this cycle
- Incremental sales over the last two years have been highly profitable as its earnings per share increased by 36.1% annually, topping its revenue gains
- Stellar return on equity showcases management’s ability to surface highly profitable business ventures
Shift4’s stock price of $42.35 implies a valuation ratio of 7.5x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
Halozyme Therapeutics (HALO)
Trailing 12-Month Free Cash Flow Margin: 46.2%
Known for transforming hours-long intravenous infusions into minutes-long subcutaneous injections, Halozyme Therapeutics (NASDAQ: HALO) develops and licenses its proprietary ENHANZE technology that enables subcutaneous delivery of injectable drugs that would otherwise require intravenous administration.
Why Could HALO Be a Winner?
- Annual revenue growth of 39.2% over the last five years was superb and indicates its market share increased during this cycle
- Notable projected revenue growth of 25.8% for the next 12 months hints at market share gains
- Earnings per share grew by 35.6% annually over the last five years, massively outpacing its peers
Halozyme Therapeutics is trading at $67.08 per share, or 8.1x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Patterson-UTI (PTEN)
Trailing 12-Month Free Cash Flow Margin: 7.7%
Operating 135 Tier-1 super-spec rigs that can handle the industry's most demanding drilling projects, Patterson-UTI (NASDAQ: PTEN) provides contract drilling rigs, hydraulic fracturing, and drill bits to oil and gas operators.
Why Do We Like PTEN?
- Annual revenue growth of 34.1% over the last five years was superb and indicates its market share increased during this cycle
- $4.83 billion in revenue gives its scale, which leads to bargaining power with suppliers and retailers
- EBITDA margin expanded by 5.5 percentage points over the last five years as it scaled and became more efficient
At $10.09 per share, Patterson-UTI trades at 6x forward EV-to-EBITDA. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
